/NOX
NOX
Updated 21 Nov 08:02 am
$0.037
NOXOPHARM LIMITED
1D+2.78%
1M-32.73%
1Y-58.43%
Track your position in NOX
Sign in to TradeLedgr to record trades in NOX (NOXOPHARM LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
19 Nov 2026 9:36 PM
Change of Director's Interest Notice219KB
Change of Director's Interest Notice
19 Nov 2026 9:36 PM
Change of Director's Interest Notice218KB
Change of Director's Interest Notice
19 Nov 2026 9:35 PM
Change of Director's Interest Notice241KB
Change of Director's Interest Notice
19 Nov 2026 9:26 PM
Cleansing Statement294KB
Cleansing Notice
19 Nov 2026 9:25 PM
Application for quotation of securities - NOX11KB
Appendix 2A
Fundamentals
P/E Ratio
—
Div Yield
0.00%
EPS
$-0.0150
Avg Vol
—
52W High
$0.110
52W Low
$0.032
Company Profile
Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock).
Corporate WebsiteFinancial History
2026A
$-4.5M profit
$1.4M rev
2025A
$-4.9M profit
$2.8M rev
2024A
$-3.6M profit
$2.4M rev